Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Anesthesiology
Published in: BMC Anesthesiology 1/2020

Open Access 01-12-2020 | Kidney Transplantation | Research article

Delayed remnant kidney function recovery is less observed in living donors who receive an analgesic, intrathecal morphine block in laparoscopic nephrectomy for kidney transplantation: a propensity score-matched analysis

Authors: Jaesik Park, Minju Kim, Yong Hyun Park, Misun Park, Jung-Woo Shim, Hyung Mook Lee, Yong-Suk Kim, Young Eun Moon, Sang Hyun Hong, Min Suk Chae

Published in: BMC Anesthesiology | Issue 1/2020

Login to get access

Abstract

Background

This study analyzed remnant kidney function recovery in living donors after laparoscopic nephrectomy to establish a risk stratification model for delayed recovery and further investigated clinically modifiable factors.

Patients and methods

This retrospective study included 366 adult living donors who underwent elective donation surgery between January 2017 and November 2019 at our hospital. ITMB was included as an analgesic component in the living donor strategy for early postoperative pain relief from November 2018 to November 2019 (n = 116). Kidney function was quantified based on the estimated glomerular filtration rate (eGFR), and delayed functional recovery of remnant kidney was defined as eGFR < 60 mL/min/1.73 m2 on postoperative day (POD) 1 (n = 240).

Results

Multivariable analyses revealed that lower risk for development of eGFR < 60 mL/min/1.73 m2 on POD 1 was associated with ITMB, female sex, younger age, and higher amount of hourly fluid infusion (area under the receiver operating characteristic curve = 0.783; 95% confidence interval = 0.734–0.832; p < 0.001). Propensity score (PS)-matching analyses showed that prevalence rates of eGFR < 60 mL/min/1.73 m2 on PODs 1 and 7 were higher in the non-ITMB group than in the ITMB group. ITMB adjusted for PS was significantly associated with lower risk for development of eGFR < 60 mL/min/1.73 m2 on POD 1 in PS-matched living donors. No living donors exhibited severe remnant kidney dysfunction and/or required renal replacement therapy at POD 7.

Conclusions

We found an association between the analgesic impact of ITMB and better functional recovery of remnant kidney in living kidney donors. In addition, we propose a stratification model that predicts delayed functional recovery of remnant kidney in living donors: male sex, older age, non-ITMB, and lower hourly fluid infusion rate.
Appendix
Available only for authorised users
Literature
1.
Kasiske BL, Snyder J, Matas A, Collins A. The impact of transplantation on survival with kidney failure. Clin Transpl. 2000:135–43.
2.
Cecka JM. Kidney transplantation in the United States. Clin Transpl. 2008:1–18.
3.
Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995;333:333–6.PubMed
4.
Muzaale AD, Massie AB, Wang MC, Montgomery RA, McBride MA, Wainright JL, et al. Risk of end-stage renal disease following live kidney donation. JAMA. 2014;311:579–86.PubMedPubMedCentral
5.
Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, et al. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med. 2016;374:411–21.PubMed
6.
Schroppel B, Legendre C. Delayed kidney graft function: from mechanism to translation. Kidney Int. 2014;86:251–8.PubMed
7.
Warltier DC, Pagel PS, Kersten JR. Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology. 2000;92:253–9.PubMed
8.
Zubrzycki M, Liebold A, Skrabal C, Reinelt H, Ziegler M, Perdas E, et al. Assessment and pathophysiology of pain in cardiac surgery. J Pain Res. 2018;11:1599–611.PubMedPubMedCentral
9.
Menjivar A, Torres X. Assessment of donor satisfaction as an essential part of living donor kidney transplantation: an eleven-year retrospective study. Transplant Int. 2018;31:1332–44.
10.
Jun JH, Kim GS, Lee JJ, Ko JS, Kim SJ, Jeon PH. Comparison of intrathecal morphine and surgical-site infusion of ropivacaine as adjuncts to intravenous patient-controlled analgesia in living-donor kidney transplant recipients. Singap Med J. 2017;58:666–73.
11.
Koning MV, Teunissen AJW, van der Harst E, Ruijgrok EJ, Stolker RJ. Intrathecal morphine for laparoscopic segmental colonic resection as part of an enhanced recovery protocol: a randomized controlled trial. Reg Anesth Pain Med. 2018;43:166–73.PubMed
12.
Ko JS, Choi SJ, Gwak MS, Kim GS, Ahn HJ, Kim JA, et al. Intrathecal morphine combined with intravenous patient-controlled analgesia is an effective and safe method for immediate postoperative pain control in live liver donors. Liver Transpl. 2009;15:381–9.PubMed
13.
Lentine KL, Kasiske BL, Levey AS, Adams PL, Alberu J, Bakr MA, et al. KDIGO clinical practice guideline on the evaluation and Care of Living Kidney Donors. Transplantation. 2017;101:S1–s109.PubMed
14.
Seo SI, Kim JC, Hwangbo K, Park YH, Hwang TK. Comparison of hand-assisted laparoscopic and open donor nephrectomy: a single-center experience from South Korea. J Endourol. 2005;19:58–62.PubMed
15.
Tabrizian P, Giacca M, Prigoff J, Tran B, Holzner ML, Chin E, et al. Renal safety of intravenous ketorolac use after donor nephrectomy. Prog Transplant. 2019;29:283–6.PubMed
16.
Campsen J, Call T, Allen CM, Presson AP, Martinez E, Rofaiel G, et al. Prospective, double-blind, randomized clinical trial comparing an ERAS pathway with ketorolac and pregabalin versus standard of care plus placebo during live donor nephrectomy for kidney transplant. Am J Transplant. 2019;19:1777–81.PubMed
17.
Freedland SJ, Blanco-Yarosh M, Sun JC, Hale SJ, Elashoff DA, Rajfer J, et al. Effect of ketorolac on renal function after donor nephrectomy. Urology. 2002;59:826–30.PubMed
18.
Freedland SJ, Blanco-Yarosh M, Sun JC, Hale SJ, Elashoff DA, Litwin MS, et al. Ketorolac-based analgesia improves outcomes for living kidney donors. Transplantation. 2002;73:741–5.PubMed
19.
Rege A, Leraas H, Vikraman D, Ravindra K, Brennan T, Miller T, et al. Could the use of an enhanced recovery protocol in laparoscopic donor nephrectomy be an incentive for live kidney donation? Cureus. 2016;8:e889.PubMedPubMedCentral
20.
Cywinski JB, Parker BM, Xu M, Irefin SA. A comparison of postoperative pain control in patients after right lobe donor hepatectomy and major hepatic resection for tumor. Anesth Analg. 2004;99:1747–52 table of contents.PubMed
21.
Kang R, Chin KJ. Bilateral single-injection erector spinae plane block versus intrathecal morphine for postoperative analgesia in living donor laparoscopic hepatectomy: a randomized non-inferiority trial; 2019.
22.
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–54.PubMed
23.
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–47.PubMed
24.
Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309:71–82.PubMedPubMedCentral
25.
Elliott WJ. Systemic hypertension. Curr Probl Cardiol. 2007;32:201–59.PubMed
26.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.PubMed
27.
Alam MN, Uddin MJ, Rahman KM, Ahmed S, Akhter M, Nahar N, et al. Electrolyte changes in stroke. Mymensingh Med J. 2012;21:594–9.PubMed
28.
Elgendy H, Helmy HAR. Intrathecal morphine improves hemodynamic parameters and analgesia in patients undergoing aortic valve replacement surgery: a prospective, double-blind, randomized trial. Pain Physician. 2017;20:405–12.PubMed
29.
Lee SH, Gwak MS, Choi SJ, Park HG, Kim GS, Kim MH, et al. Prospective, randomized study of ropivacaine wound infusion versus intrathecal morphine with intravenous fentanyl for analgesia in living donors for liver transplantation. Liver Transpl. 2013;19:1036–45.PubMed
30.
Sener M, Torgay A, Akpek E, Colak T, Karakayali H, Arslan G, et al. Regional versus general anesthesia for donor nephrectomy: effects on graft function. Transplant Proc. 2004;36:2954–8.PubMed
31.
Baar W, Goebel U, Buerkle H, Jaenigen B, Kaufmann K, Heinrich S. Lower rate of delayed graft function is observed when epidural analgesia for living donor nephrectomy is administered. BMC Anesthesiol. 2019;19:38.PubMedPubMedCentral
32.
Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet. 2004;364:1814–27.PubMed
33.
Daudel F, Freise H, Westphal M, Stubbe HD, Lauer S, Bone HG, et al. Continuous thoracic epidural anesthesia improves gut mucosal microcirculation in rats with sepsis. Shock. 2007;28:610–4.PubMed
34.
Nygard E, Kofoed KF, Freiberg J, Holm S, Aldershvile J, Eliasen K, et al. Effects of high thoracic epidural analgesia on myocardial blood flow in patients with ischemic heart disease. Circulation. 2005;111:2165–70.PubMed
35.
Grassi G, Bertoli S, Seravalle G. Sympathetic nervous system: role in hypertension and in chronic kidney disease. Curr Opin Nephrol Hypertens. 2012;21:46–51.PubMed
36.
Bellini MI, Charalampidis S, Stratigos I, Dor F, Papalois V. The effect of donors’ demographic characteristics in renal function post-living kidney donation. analysis of a UK single centre cohort. J Clin Med. 2019;8:883.PubMedCentral
37.
Massie AB, Muzaale AD, Luo X, Chow EKH, Locke JE, Nguyen AQ, et al. Quantifying postdonation risk of ESRD in living kidney donors. J Am Soc Nephrol. 2017;28:2749–55.PubMedPubMedCentral
38.
Okumura K, Yamanaga S. Prediction model of compensation for contralateral kidney after living-donor donation. BMC Nephrol. 2019;20:283.PubMedPubMedCentral
39.
Neugarten J, Golestaneh L, Kolhe NV. Sex differences in acute kidney injury requiring dialysis. BMC Nephrol. 2018;19:131.PubMedPubMedCentral
40.
Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. 2013;20:390–5.PubMed
41.
Hutchens MP, Dunlap J, Hurn PD, Jarnberg PO. Renal ischemia: does sex matter? Anesth Analg. 2008;107:239–49.PubMed
42.
Metcalfe PD, Meldrum KK. Sex differences and the role of sex steroids in renal injury. J Urol. 2006;176:15–21.PubMed
43.
Neugarten J, Sandilya S, Singh B, Golestaneh L. Sex and the risk of AKI following cardio-thoracic surgery: a meta-analysis. Clin J Am Soc Nephrol. 2016;11:2113–22.PubMedPubMedCentral
44.
McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013;173:1821–8.PubMedPubMedCentral
45.
Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393–9.PubMed
46.
Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med. 1984;100:352–7.PubMed
47.
Dols LF, Kok NF, Roodnat JI, Tran TC, Terkivatan T, Zuidema WC, et al. Living kidney donors: impact of age on long-term safety. Am J Transplant. 2011;11:737–42.PubMed
48.
Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–83.PubMed
49.
Ostermann M, Liu K, Kashani K. Fluid management in acute kidney injury. Chest. 2019;156:594–603.PubMed
50.
Shin CH, Long DR, McLean D, Grabitz SD, Ladha K, Timm FP, et al. Effects of intraoperative fluid management on postoperative outcomes: a hospital registry study. Ann Surg. 2018;267:1084–92.PubMed
51.
Varadhan KK, Lobo DN. A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc. 2010;69:488–98.PubMed
52.
Bundgaard-Nielsen M, Secher NH, Kehlet H. ‘Liberal’ vs. ‘restrictive’ perioperative fluid therapy--a critical assessment of the evidence. Acta Anaesthesiol Scand. 2009;53:843–51.PubMed
53.
Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10:37–47.PubMed
54.
Mertens zur Borg IR, Di Biase M, Verbrugge S, Ijzermans JN, Gommers D. Comparison of three perioperative fluid regimes for laparoscopic donor nephrectomy : A prospective randomized dose-finding study. Surg Endosc. 2008;22:146–50.PubMed
55.
Raimundo M, Crichton S, Martin JR, Syed Y, Varrier M, Wyncoll D, et al. Increased fluid administration after early acute kidney injury is associated with less renal recovery. Shock. 2015;44:431–7.PubMed
56.
Finfer S, Myburgh J, Bellomo R. Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol. 2018;14:541–57.PubMed
57.
Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107–15.PubMed
58.
Skytte Larsson J, Bragadottir G, Krumbholz V, Redfors B, Sellgren J, Ricksten SE. Effects of acute plasma volume expansion on renal perfusion, filtration, and oxygenation after cardiac surgery: a randomized study on crystalloid vs colloid. Br J Anaesth. 2015;115:736–42.PubMed
59.
Schlereth T, Birklein F. The sympathetic nervous system and pain. NeuroMolecular Med. 2008;10:141–7.PubMed
60.
Hoiseth LO, Hisdal J, Hoff IE, Hagen OA, Landsverk SA, Kirkeboen KA. Tissue oxygen saturation and finger perfusion index in central hypovolemia: influence of pain. Crit Care Med. 2015;43:747–56.PubMed
61.
Ljungqvist O. ERAS--enhanced recovery after surgery: moving evidence-based perioperative care to practice. JPEN J Parenter Enteral Nutr. 2014;38:559–66.PubMed
Metadata
Title
Delayed remnant kidney function recovery is less observed in living donors who receive an analgesic, intrathecal morphine block in laparoscopic nephrectomy for kidney transplantation: a propensity score-matched analysis
Authors
Jaesik Park
Minju Kim
Yong Hyun Park
Misun Park
Jung-Woo Shim
Hyung Mook Lee
Yong-Suk Kim
Young Eun Moon
Sang Hyun Hong
Min Suk Chae
Publication date
01-12-2020

Other articles of this Issue 1/2020

BMC Anesthesiology 1/2020 Go to the issue

Research article

Effect of caudal ketamine on minimum local anesthetic concentration of ropivacaine in children: a prospective randomized trial

Research article

Conversion of I-gel to definitive airway in a cervical immobilized manikin: Aintree intubation catheter vs long endotracheal tube

Research article

The fraction of nitrous oxide in oxygen for facilitating lung collapse during one-lung ventilation with double lumen tube

Research article

Prevalence and multivariable factors associated with inadvertent intraoperative hypothermia in video-assisted thoracoscopic surgery: a single-center retrospective study

Research article

Laryngeal mask versus facemask in the respiratory management during catheter ablation

Research article

Sufentanil postoperative analgesia reduce the increase of T helper 17 (Th17) cells and FoxP3+ regulatory T (Treg) cells in rat hepatocellular carcinoma surgical model: A randomised animal study